New gel shows promise for diabetic foot wounds
NCT ID NCT06111183
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new gel called AUP1602-C on 64 people with diabetes who had foot ulcers that were not healing. The gel was applied directly to the wound and covered with a dressing. The goal was to see if it is safe and helps wounds close faster compared to a placebo gel. The trial is now complete, and results will show whether this treatment could become a new option for diabetic foot care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AUP1602-C (a biological gel applied to wounds)
What this could lead to
If successful, this could provide a new treatment option to help heal stubborn diabetic foot ulcers, reducing the risk of infection and amputation.
What could go wrong
This is an early Phase 2 trial with only 64 participants, so results may not apply to everyone. The treatment may not work better than standard care or placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AOU Pisana - Ospedale S. Chiara
Pisa, Italy
-
Azienda Ospedaliero-Universitaria Careggi
Florence, Italy
-
Hauärztliche und Diabetologische Praxis
Pirna, Germany
-
Institut für Diabetesforschung Muenster GmbH
Münster, Germany
-
Lecran Centrum Opieki Nad Ranami
Wroclaw, Poland
-
Med-Polonia SP. Z O.O.
Poznan, Poland
-
Mikomed
Lodz, Poland
-
Ospedale S. Jacopo Pistoia, Diabetologia e Diabetic foot unit Aziendale
Pistoia, Italy
-
Ospedale San Donato
Arezzo, Italy
-
PODOS Klinika Leczenia Ran Podema sp. z o.o.
Warsaw, Poland